Patterns and prognostic value of total and differential leukocyte count in chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 6, 2011, Pages 1393-1399

  Agarwal, Rajiv ^a   Light, Robert P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; HAZARD RATIO; HEART INFARCTION; HUMAN; KIDNEY FAILURE; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; VETERAN;

AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DISEASE PROGRESSION; EOSINOPHILS; FEMALE; GRANULOCYTES; HUMANS; INDIANA; INFLAMMATION; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; VETERANS;

EID: 79958185810     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10521110     Document Type: Article

References (19)

1. Vannini FD, Antunes AA, Caramori JC, Martin LC, Barretti P: Associations between nutritional markers and inflammation in hemodialysis patients. Int Urol Nephrol 41: 1003-1009, 2009
2. Manjunath G, Sarnak MJ, Levey AS: Prediction equations to estimate glomerular filtration rate: An update. Curr Opin Nephrol Hypertens 10: 785-792, 2001
3. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288: 2421-2431, 2002
4. Gabbasov ZA, Kozlov SG, Lyakishev AA, Saburova OS, Smirnov VA, Smirnov VN: Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents. Can J Physiol Pharmacol 87: 130-136, 2009
5. Holden JE, Kelley K, Agarwal R: Analyzing change: A primer on multilevel models with applications to nephrology. Am J Nephrol 28: 792-801, 2008
6. Feiveson Al: TRYEM: Stata module to run all possible subset regressions. Computer program, November 30, 2006
7. Bouts AH, Out TA, Schroder CH, Monnens LA, Nauta J, Krediet RT, Davin JC: Characteristics of peripheral and peritoneal white blood cells in children with chronic renal failure, dialyzed or not. Perit Dial Int 20: 748-756, 2000
8. Hulstaert F, Hannet I, Deneys V, Munhyeshuli V, Reichert T, De B.M, Strauss K: Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin Immunol Immunopathol 70: 152- 158, 1994
9. MacKinney AA Jr: Effect of aging on the peripheral blood lymphocyte count. J Gerontol 33: 213-216, 1978
10. Bender BS, Nagel JE, Adler WH, Andres R: Absolute peripheral blood lymphocyte count and subsequent mortality of elderly men. The Baltimore Longitudinal Study of Aging. J Am Geriatr Soc 34: 649-654, 1986
11. Ferrucci L, Guralnik JM, Bandinelli S, Semba RD, Lauretani F, Corsi A, Ruggiero C, Ershler WB, Longo DL: Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol 136: 849-855, 2007
12. Litjens NH, van Druningen CJ, Betjes MG: Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol 118: 83-91, 2006
13. Gabizon D, Kaufman S, Shaked U, Evans SY, Modai D: Eosinophilia in uremia. Nephron 29: 36-39, 1981
14. Hallgren R, Grefberg N, Venge P: Elevated circulating levels of eosinophil cationic protein in uremia as signs of abnormal eosinophil homeostasis. Nephron 36: 10-14, 1984
15. Kelly KJ, Dominguez JH: Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am J Nephrol 32: 469-475, 2010
16. Pifer TB, McCullough KP, Port FK, Goodkin DA, Maroni BJ, Held PJ, Young EW: Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 62: 2238-2245, 2002
17. Fukui M, Tanaka M, Hamaguchi M, Senmaru T, Sakabe K, Shiraishi E, Harusato I, Yamazaki M, Hasegawa G, Nakamura N: Eosinophil count is positively correlated with albumin excretion rate in men with type 2 diabetes. Clin J Am Soc Nephrol 4: 1761-1765, 2009
18. Kovesdy CP, George SM, Anderson JE, Kalantar-Zadeh K: Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr 90: 407-414, 2009
19. Reddan DN, Klassen PS, Szczech LA, Coladonato JA, O'Shea S, Owen WF Jr, Lowrie EG: White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant 18: 1167-1173, 2003